Illumina, Inc. offers the HumanOmniExpress BeadChip (OmniExpress) microarray for genome-wide association studies (GWAS). Designed as a 12-sample Beadchip, OmniExpress allows interrogation of over 700,000 variants per sample totaling more than eight million available data points on a single chip. Coupled with the Illumina iScan System, OmniExpress enables processing of more than 1,400 samples per week, the highest throughput in the industry.
The markers on OmniExpress are a subset of the content powering Illumina’s flagship GWAS product, the HumanOmni1-Quad, and incorporate an optimized set of SNPs chosen from all three phases of the International HapMap Project. As with the HumanOmni1, researchers starting with OmniExpress can take advantage of future supplemental Omni BeadChips containing new content derived from the 1000 Genomes Project.
The OmniExpress BeadChip supports copy number variation (CNV) analyses for disease-association studies and is compatible with Illumina’s automation solutions. First customer shipments of the OmniExpress are expected in the first quarter of 2010.
Filed Under: Drug Discovery
